Rh-Gcsf Injection 300mcg

About Rh-Gcsf Injection 300mcg

Rh-Gcsf Injection Uses

• Raises neutrophil counts in patients with chemotherapy induced neutropenia
• Reduces the risk and duration of fever linked to low white cell counts
• Supports bone marrow recovery after certain cancer treatments
• Used before stem cell collection to mobilize cells into the bloodstream
• Helps manage severe chronic neutropenia in select patients
• Assists recovery after bone marrow transplantation under specialist care

Rh-Gcsf Injection Benefits

• Shortens the period of dangerously low white blood cell counts
• Lowers the chance of serious infection during cancer treatment
• Allows chemotherapy cycles to continue on schedule
• Supports faster recovery after intensive treatment protocols

What Experts Say

Oncologists prescribe filgrastim for patients whose white blood cell counts fall dangerously low after chemotherapy, since this drop leaves the body vulnerable to severe infection. Hematologists also use it before stem cell collection procedures in transplant patients, and it is a standard part of supportive cancer care protocols.

The medicine copies a natural human protein called granulocyte colony-stimulating factor. It signals the bone marrow to produce and release more neutrophils, the white blood cells that fight bacterial infection, helping counts recover faster than they would on their own.

Cancer centers in major cities increasingly rely on this injection to keep chemotherapy schedules on track without dangerous treatment delays. Because dosing depends on body weight, blood counts and the specific chemotherapy regimen, it is administered and monitored strictly within hospital or oncology day care settings, with pharmacy staff handling cold chain storage and transport between visits.

Drug Class

• Colony-stimulating factor (hematopoietic growth factor)

Rh-Gcsf Injection 300mcg formula

• Filgrastim (Recombinant Human Granulocyte Colony-Stimulating Factor)

Available forms

• Injection (pre-filled syringe or vial)

How to use Rh-Gcsf Injection 300mcg?

• Receive this injection only under the supervision of an oncologist or trained hospital staff
• Follow the exact dose and schedule calculated for the specific chemotherapy protocol
• Undergo regular blood count monitoring throughout the course
• Report bone pain, fever or breathing difficulty to the care team promptly
• Store and transport the injection according to strict cold chain instructions
• Never attempt to adjust the dose or self administer without medical direction

Drug Interactions

• Chemotherapy agents: Timing around chemotherapy cycles is carefully planned since giving it too close to chemotherapy can worsen low blood counts.
• Lithium: Lithium can further increase white blood cell release and needs monitoring when used together.
• Other bone marrow stimulating drugs: Combining growth factors is avoided unless specifically directed by a hematologist.

Risks and warnings

• Specialist administration only: This is a hospital or oncology administered injection, not intended for unsupervised home use.
• Bone pain: Increased bone marrow activity commonly causes aching in the back, hips or long bones.
• Spleen enlargement: Rarely, the spleen can enlarge or, very rarely, rupture, so sudden left sided abdominal pain needs urgent evaluation.
• Allergic reaction: Serious hypersensitivity reactions can occur and require immediate medical attention.
• Lung complications: Rare cases of acute respiratory distress have been reported, so new breathing difficulty must be reported at once.
• Sickle cell disease: Patients with sickle cell disorders need cautious use due to a risk of sickle cell crisis.

Rh-Gcsf Injection Side Effects

• Bone and joint pain
• Injection site redness
• Headache
• Fatigue
• Muscle aches
• Nausea
• Low grade fever
• Reduced platelet count

Storage Conditions

• Store refrigerated between 2°C and 8°C
• Protect from freezing and from direct light
• Transport in a cold chain container between hospital and pharmacy
• Keep out of reach of children.